LILLY CORPORATE CTR, INDIANAPOLIS, IN
Reports Fourth-Quarter 2025 Financial Results and Provides 2026 Guidance
Board Appointment - Carolyn R. Bertozzi Joins Eli Lilly Board
Reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion
Reports second-quarter 2025 financial results and raises guidance
Shareholder votes
Reports First-Quarter 2025 Financial Results and Highlights Pipeline Momentum
FY 2024
Q3
Q2
Q1
FY 2023
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Prospectus Filed Pursuant to Rule 424(b)(2)
S-3ASR
Definitive Additional Information Statement
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Additional Proxy Soliciting Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Third Party
Free Writing Prospectus